| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 06/29/2005 | EP1545571A2 Herbs and herbal combinations useful for the treatment of microbial infections |
| 06/29/2005 | EP1545563A1 Composition and method for use in intestinal cleansing procedures |
| 06/29/2005 | EP1545555A2 Compositions and methods for treating epithelial and retinal tissue diseases |
| 06/29/2005 | EP1545552A1 Combination therapy wherein a serotonin reuptake inhibitor is used |
| 06/29/2005 | EP1545538A2 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 06/29/2005 | EP1545523A1 3-&-grave;(HETERO) ARYLMETHOXY ! PYRIDINES AND THEIR ANALOGUES ASP38 MAP KINASE INHIBITORS |
| 06/29/2005 | EP1545522A1 Use of vanilloid receptor antagonists for the treatment of pain |
| 06/29/2005 | EP1545516A2 Topical formulation comprising at least 5% of metronidazole in white petrolatum and its use in the anal and rectal region |
| 06/29/2005 | EP1545488A1 Choline ascorbate formulations |
| 06/29/2005 | EP1545475A1 Enteric composition for the manufacture of soft capsule wall |
| 06/29/2005 | EP1408943B1 Pharmaceutical formulation containing an ltb4 antagonist and a wetting agent |
| 06/29/2005 | EP1343786B1 Novel pyridine-substituted pyrazolopyridine derivatives |
| 06/29/2005 | EP1315727B1 7-oxo pyridopyrimidines |
| 06/29/2005 | EP1315473B1 Use of ectoine or ectoine derivatives for oral care |
| 06/29/2005 | EP1274701B1 [1,4']-bipiperidine compounds |
| 06/29/2005 | EP0773957B1 Secreted hepatitis C virus E1/E2 complex obtained from C-terminally truncated E1 and E2 polypeptides |
| 06/29/2005 | CN1633498A Novel insulin/IGF/relaxin family polypeptides and dnas thereof |
| 06/29/2005 | CN1633446A Novel peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 06/29/2005 | CN1633444A 6-11 bicyclic ketolide derivatives |
| 06/29/2005 | CN1633435A Tricyclic n-acyl compounds |
| 06/29/2005 | CN1633433A N-aroyl cyclic amines |
| 06/29/2005 | CN1633420A Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors |
| 06/29/2005 | CN1633414A Chemical compounds |
| 06/29/2005 | CN1633301A Extracts from sophora, production method and purposes thereof |
| 06/29/2005 | CN1633299A Estrogen replacement therapy |
| 06/29/2005 | CN1633296A Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/29/2005 | CN1633294A 2, 4, 5-trisubstituded thiazolyl derivatives and their antiinflammatory activity |
| 06/29/2005 | CN1633293A 5-ht2b receptor antagonists |
| 06/29/2005 | CN1633291A 2-oxazolamines and their use as 5-ht2b receptor antagonists |
| 06/29/2005 | CN1633289A Hemiasterlin derivatives and uses thereof |
| 06/29/2005 | CN1633288A Use of genistein in the manufacture of a medicament for the treatment of osteoporosis and obesity, and compositions containing genistein in combination with vitamin d and k |
| 06/29/2005 | CN1633285A 组合物 The composition |
| 06/29/2005 | CN1633284A Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 06/29/2005 | CN1631900A Method for preparing antler polypeptide and medicine with the antler polypeptide as main active component |
| 06/29/2005 | CN1631895A Preparation method of amygdalin and its application in preparation of amygdalin preparation for promoting the blood circulation of heart, brain, pancreas and wound |
| 06/29/2005 | CN1631443A Targeted small interference RNA formulation for preventing and treating Hepatitis C and its preparation method |
| 06/29/2005 | CN1631442A Targeted small interference RNA formulation for treating viral Hepatitis B and its preparation |
| 06/29/2005 | CN1631437A Method for extracting and synthesizing thymus microcapsule sustained release needle by PLGA |
| 06/29/2005 | CN1631436A Method for extracting and synthesizing alpha -2b microcapsule sustained release needle by PLGA |
| 06/29/2005 | CN1631431A Method for extracting ganoderma lucidum spore fat soluble active substance and its specified instrument for preparation |
| 06/29/2005 | CN1631419A Phacellanthus extractive, its preparation and medical application |
| 06/29/2005 | CN1631418A Medicine for treating chronic ulcerative colitis and its preparation process |
| 06/29/2005 | CN1631413A Medicine for treating chronic colitis and its preparing process |
| 06/29/2005 | CN1631411A Medicine for easing pain and reinforcing teeth |
| 06/29/2005 | CN1631406A Tablet formulation of 'Jingui Shenqi', its preparation and derivative formulation |
| 06/29/2005 | CN1631403A Pharmaceutical composition for treating constipation, its formulation and preparation process thereof |
| 06/29/2005 | CN1631386A Navel plastered film for treating infantile diarrhea |
| 06/29/2005 | CN1631380A Pharmaceutical composition for treating peptic ulcer and its preparation method |
| 06/29/2005 | CN1631377A Magnetic gastricantiacids intermediate and its preparing method |
| 06/29/2005 | CN1631373A Enteric coated formulation of Coriolus Versicolor Polysaccharide and its preparation process |
| 06/29/2005 | CN1631217A Concentrated solution of acanthopanax root, royal jelly, pollen and honey and method for making it |
| 06/29/2005 | CN1208463C Differential cytotoxicity of alternative forms of rotavirus nonstructural protein 4 |
| 06/29/2005 | CN1208333C Indole derivatives useful for the treatment of osteoporosis |
| 06/29/2005 | CN1208330C Method for extracting red-rooted salvia root anti-peptic ulcer effective part |
| 06/29/2005 | CN1208329C Aniline derivatives |
| 06/29/2005 | CN1208322C Dihydroindole and tetrahydroquinoline derivatives |
| 06/29/2005 | CN1208093C Pharmaceutical composition and process thereof |
| 06/29/2005 | CN1208084C Proprietary Chineae traditional medicine for curing chronix virus B hepatitis and its preparation method |
| 06/29/2005 | CN1208083C Chinese traditional medicine composition curing viscera inflammation, toxin and endocrine disorder |
| 06/29/2005 | CN1208082C Yunan red drug tablet , its preparation method and use |
| 06/29/2005 | CN1208075C Preparation method of healthy fermentative wine |
| 06/29/2005 | CN1208043C Oral cavity disinfectant liquor |
| 06/28/2005 | US6911542 Pyrazino[1′,2′:1,6]pyrido[3,4b]indole derivatives |
| 06/28/2005 | US6911458 Compounds |
| 06/28/2005 | US6911452 Central nervous system disorders, sleep disorders, eating disorders. sexual disorders, hypotensive agents |
| 06/28/2005 | US6911444 Non-steroidal IL-5 inhibitors, processes and intermediates for their preparation and pharmaceutical compositions comprising said inhibitors |
| 06/28/2005 | US6911443 Imidazopyrimidine derivatives and triazolopyrimidine derivatives |
| 06/28/2005 | US6911440 For the treatment of inflammatory rheumatic/rheumatoid diseases and/or pain, rheumatoid arthritis |
| 06/28/2005 | US6911439 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents |
| 06/28/2005 | US6911426 Inhibitor of apoptosis proteins (IAP); survivin |
| 06/28/2005 | US6911211 Pharmaceutical and cosmetic carrier or composition for topical application |
| 06/28/2005 | CA2252661C Storage stable dentifrice composition containing casein glycomacropeptide |
| 06/23/2005 | WO2005055999A1 Anticholinergic agent |
| 06/23/2005 | US20050137414 New aminopropylphosphinic acids |
| 06/23/2005 | US20050137249 Cyclization at the 5,6-position of the benzo[e]naphtho[3,2-h]azulene, oxepane or thiepane with a mercaptoacetic acid ester followed by etherification, amination or sulfiding at the 2-position; antiarthritic and antiinflammatory agents, analgesics; biosynthesis inhibitors of interleukin-1; nontoxic |
| 06/23/2005 | US20050137167 Inhibiting FGF growth factor with heparins; antitumor agents; angiogenesis inhibitor; antidiabetic agent treating diabetic retinopathy; antiinflammatory agent; treating retrolenticular fibroplasia, psoriasis, restenosis after angioplasty and after coronary by-pass; chemical intermediates; drug delivery |
| 06/23/2005 | US20050137161 Methods and compositions for treating hepatitis C virus |
| 06/23/2005 | US20050137148 treating an infectious disease associated with narrowing or obstruction of a body passageway by delivering to an external portion of the body passageway an antibiotic; infections such as pelvic inflammatory disease, urethritis, or tuberculosis |
| 06/23/2005 | US20050137135 Novel analogues of glucose-dependent insulinotropic polypeptide |
| 06/23/2005 | US20050136162 Enzymatic treatment with intermittent wet milling; heat treating; centrifugation and ultrafiltration separation; high value protein, fat, sugar, fiber and phytate fractions of distinct properties; low cost |
| 06/23/2005 | US20050136133 Administering an anti-allergy composition of a wood-vinegar distilled solution, colorless and transparent |
| 06/23/2005 | US20050136127 Trimebutine and/or fedotozine combined with laxatives, antidiarrheals, antibiotics, antiulceratives, gastric secretion inhibitors, peristalitc stimulants, serotonin (5HT3) receptor antagonists, serotonin (5HT4) receptor agonists and/or selective serotonin reuptake inhibitors |
| 06/23/2005 | US20050136070 Isolation and characterization of the csa operon (ETEC-CS4 Pili) and methods of using same |
| 06/23/2005 | US20050136030 with cholestyramine or colestipol; kit for treating obesity |
| 06/23/2005 | DE10357110A1 Composition for topical treatment of diseases of teeth and gums, comprises Verbena officinalis and/or Plantago lanceolata, or their extracts, inhibits many oral bacteria |
| 06/23/2005 | CA2549404A1 Compositions and methods for the treatment of lysosomal storage disorders |
| 06/23/2005 | CA2548559A1 Intranasal compositions comprising granisetron and chitosan |
| 06/23/2005 | CA2548149A1 Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption |
| 06/23/2005 | CA2547911A1 Dietary non-essential amino acid tyrosine regulates the body weight of animals through regulating the animal appetite or food intake |
| 06/23/2005 | CA2490218A1 Extracorporeal photopheresis in combination with anti-tnf treatment |
| 06/22/2005 | EP1544304A1 Novel serine protease |
| 06/22/2005 | EP1543833A1 Phosphorylated dextran |
| 06/22/2005 | EP1543039A1 Novel immunogenic lipopeptides comprising t-helper and b-cell epitopes |
| 06/22/2005 | EP1543034A2 Treatment and prophylaxis with 4-1bb-binding agents |
| 06/22/2005 | EP1543024A2 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 06/22/2005 | EP1543005A1 Imidazopyridine compunds as 5-ht4 receptor agonists |
| 06/22/2005 | EP1543003A2 Imidazo[1,2-a]pyridines |
| 06/22/2005 | EP1542984A2 Methods of purifying cannabinoids from plant material |
| 06/22/2005 | EP1542980A1 5-aryltetrazole compounds, compositions thereof, and uses therefor |
| 06/22/2005 | EP1542978A1 Novel bio-active molecules |